Indirect acting agents – Propylhexedrine MCQs With Answer

Indirect acting agents – Propylhexedrine MCQs With Answer

Propylhexedrine is an indirect-acting sympathomimetic used mainly as a topical nasal decongestant in inhalers. This introduction reviews its mechanism—displacing norepinephrine from presynaptic terminals—therapeutic uses, pharmacokinetics, adverse effects, abuse potential, and important drug interactions relevant to B.Pharm students. Key concepts include receptor targets, structural relation to amphetamines, onset and duration of action, contraindications (e.g., MAO inhibitors, hypertension), and safe dispensing practices. These MCQs will deepen your understanding of propylhexedrine’s pharmacology, clinical implications, and regulatory considerations. Now let’s test your knowledge with 50 MCQs on this topic.

Q1. What is the primary mechanism of action of propylhexedrine?

• Direct agonism at alpha-1 adrenergic receptors
• Inhibition of norepinephrine reuptake transporters
• Displacement of norepinephrine from presynaptic vesicles (indirect sympathomimetic)
• Monoamine oxidase inhibition

Correct Answer: Displacement of norepinephrine from presynaptic vesicles (indirect sympathomimetic)

Q2. Propylhexedrine is most commonly formulated for which route of administration?

• Oral tablets
• Intravenous injection
• Topical nasal inhaler
• Transdermal patch

Correct Answer: Topical nasal inhaler

Q3. Structurally, propylhexedrine is most closely related to which class of compounds?

• Beta-lactam antibiotics
• Cyclohexylamines related to amphetamines
• Nonsteroidal anti-inflammatory drugs

Correct Answer: Cyclohexylamines related to amphetamines

Q4. Which of the following therapeutic effects is propylhexedrine primarily used for?

• Bronchodilation in asthma
• Reduction of nasal mucosal congestion
• Systemic blood pressure lowering
• Analgesia for headaches

Correct Answer: Reduction of nasal mucosal congestion

Q5. Which receptor-mediated effect contributes to the decongestant action of propylhexedrine?

• Beta-2 mediated bronchodilation
• Alpha-1 mediated vasoconstriction of nasal mucosa
• Dopamine D2 receptor blockade
• Muscarinic receptor antagonism

Correct Answer: Alpha-1 mediated vasoconstriction of nasal mucosa

Q6. Propylhexedrine is classified as which type of sympathomimetic?

• Direct-acting
• Indirect-acting
• Mixed-acting with strong direct agonism
• Selective beta-1 agonist

Correct Answer: Indirect-acting

Q7. What is a common local adverse effect associated with topical propylhexedrine use?

• Rebound congestion (rhinitis medicamentosa)
• Gastrointestinal bleeding
• Hepatotoxicity
• Renal failure

Correct Answer: Rebound congestion (rhinitis medicamentosa)

Q8. Combining propylhexedrine with an MAO inhibitor can cause:

• Reduced nasal efficacy
• Hypertensive crisis
• Profound hypotension
• Increased anticholinergic effects

Correct Answer: Hypertensive crisis

Q9. Which pharmacokinetic property is true for propylhexedrine administered nasally?

• Extensive first-pass hepatic metabolism reducing effect
• Rapid local onset with limited systemic absorption at recommended doses
• Long half-life of more than 24 hours
• Complete oral bioavailability

Correct Answer: Rapid local onset with limited systemic absorption at recommended doses

Q10. Abuse of propylhexedrine is associated with which effect when misused systemically?

• Sedation and respiratory depression
• Stimulant effects, euphoria, tachycardia
• Antipsychotic properties
• Strong opioid-like analgesia

Correct Answer: Stimulant effects, euphoria, tachycardia

Q11. Which patient condition is a contraindication for propylhexedrine use without medical advice?

• Controlled seasonal allergies
• Uncontrolled hypertension
• Mild eczema
• Recent viral upper respiratory infection

Correct Answer: Uncontrolled hypertension

Q12. The primary neurotransmitter released by propylhexedrine’s indirect action is:

• Serotonin
• Acetylcholine
• Norepinephrine (noradrenaline)
• GABA

Correct Answer: Norepinephrine (noradrenaline)

Q13. Which monitoring is most relevant when systemic absorption of propylhexedrine is suspected?

• Liver function tests
• Blood pressure and heart rate
• Serum creatinine
• Serum electrolytes only

Correct Answer: Blood pressure and heart rate

Q14. Which statement about propylhexedrine metabolism is correct?

• It is primarily excreted unchanged in feces
• Hepatic metabolism plays a role, producing polar metabolites for renal excretion
• It is metabolized to active benzodiazepine-like compounds
• Metabolism is exclusively via CYP3A4 leading to many interactions

Correct Answer: Hepatic metabolism plays a role, producing polar metabolites for renal excretion

Q15. A likely sign of propylhexedrine overdose is:

• Bradycardia and hypothermia
• Hypertension, tachyarrhythmia, agitation
• Severe hypoglycemia
• Profound sedation

Correct Answer: Hypertension, tachyarrhythmia, agitation

Q16. In terms of legal status and availability, propylhexedrine in many countries is:

• Prescription-only opioid
• Available over-the-counter as a nasal inhaler
• Completely banned with no legal medical use
• Available only as an injectable hospital product

Correct Answer: Available over-the-counter as a nasal inhaler

Q17. Which of the following is NOT a recommended counseling point for patients using propylhexedrine inhalers?

• Limit use to recommended duration to avoid rebound congestion
• Avoid concurrent use with MAO inhibitors
• Use higher frequency than recommended to achieve faster relief
• Report palpitations or severe headache to a healthcare provider

Correct Answer: Use higher frequency than recommended to achieve faster relief

Q18. Propylhexedrine primarily acts on which part of the autonomic nervous system?

• Parasympathetic nervous system
• Sympathetic nervous system
• Enteric nervous system
• Somatic nervous system

Correct Answer: Sympathetic nervous system

Q19. Compared to oral amphetamines, topical propylhexedrine has:

• Higher systemic stimulant effect at recommended doses
• Lower systemic bioavailability when used as directed nasally
• Equivalent regulatory control and scheduling
• Stronger antidepressant effects

Correct Answer: Lower systemic bioavailability when used as directed nasally

Q20. Which adverse effect is least likely with topical propylhexedrine at therapeutic doses?

• Local nasal irritation
• Systemic hypertension in predisposed patients
• Severe liver injury
• Rebound congestion with prolonged use

Correct Answer: Severe liver injury

Q21. Which pharmacological term best describes propylhexedrine’s action increasing release of stored neurotransmitter?

• Reuptake inhibition
• Vesicular release facilitator (indirect release)
• Enzyme activation
• Ion channel blockade

Correct Answer: Vesicular release facilitator (indirect release)

Q22. Which patient population requires extra caution when using propylhexedrine?

• Young adults without comorbidities
• Patients with cardiovascular disease
• Patients with seasonal hay fever only
• Patients currently taking topical emollients

Correct Answer: Patients with cardiovascular disease

Q23. Which laboratory finding may be seen in severe sympathomimetic toxicity from propylhexedrine misuse?

• Hypokalemia due to beta-adrenergic effects
• Marked leukopenia
• Hypoglycemia exclusively
• Elevated INR only

Correct Answer: Hypokalemia due to beta-adrenergic effects

Q24. For B.Pharm students, which concept explains tachycardia with systemic sympathomimetic exposure?

• Direct vagal stimulation
• Increased sympathetic stimulation via norepinephrine release
• Enhanced parasympathetic tone
• Blockade of beta receptors

Correct Answer: Increased sympathetic stimulation via norepinephrine release

Q25. Which interaction is potentially dangerous with propylhexedrine?

• Concurrent use with topical saline nasal sprays
• Concurrent use with MAO inhibitors or recent MAOI therapy
• Use with oral antihistamines for allergies
• Co-administration with ibuprofen for pain

Correct Answer: Concurrent use with MAO inhibitors or recent MAOI therapy

Q26. In overdose management of sympathomimetic toxicity, which agent may be used for severe hypertension?

• Nonselective beta-blockers like propranolol without caution
• Short-acting vasodilators or alpha-blockers (e.g., phentolamine) under supervision
• High-dose benzodiazepines only for bradycardia
• Administer MAO inhibitors to reverse effects

Correct Answer: Short-acting vasodilators or alpha-blockers (e.g., phentolamine) under supervision

Q27. Which symptom is characteristic of withdrawal after chronic stimulant misuse, which may apply to propylhexedrine abuse?

• Euphoria and hyperactivity
• Depression, fatigue, increased sleep
• Immediate severe nasal ulceration
• Persistent fever and rash

Correct Answer: Depression, fatigue, increased sleep

Q28. Which formulation excipient consideration is important for nasal inhalers containing propylhexedrine?

• Use of systemic steroid preservatives only
• Nonirritant solvents and appropriate propellant-free delivery
• Inclusion of ethanol at high concentrations for stability
• Oral sweeteners to improve taste

Correct Answer: Nonirritant solvents and appropriate propellant-free delivery

Q29. Which of the following best describes tolerance development with topical sympathomimetics like propylhexedrine?

• No tolerance; effects remain constant indefinitely
• Rapid tolerance leading to decreased effect and rebound with prolonged use
• Tolerance only after years of use
• Tolerance that results in stronger systemic analgesia

Correct Answer: Rapid tolerance leading to decreased effect and rebound with prolonged use

Q30. Which clinical counseling point is correct regarding duration of use for nasal decongestant inhalers?

• Use daily for several weeks to maintain decongestion
• Limit continuous use to no more than 3–7 days to avoid rhinitis medicamentosa
• Use whenever needed with no upper limit
• Avoid use for nasal congestion but use for cough

Correct Answer: Limit continuous use to no more than 3–7 days to avoid rhinitis medicamentosa

Q31. Which symptom would suggest systemic sympathetic overactivity after excessive propylhexedrine exposure?

• Bradykinesia and slurred speech
• Tachycardia, diaphoresis, mydriasis
• Hyporeflexia and somnolence
• Jaundice and hepatomegaly

Correct Answer: Tachycardia, diaphoresis, mydriasis

Q32. Which is a pharmacodynamic difference between direct and indirect sympathomimetics?

• Indirect agents act by directly binding receptors only
• Indirect agents increase endogenous transmitter availability rather than directly activating receptors
• Direct agents always cause longer duration of action
• Indirect agents never cause systemic effects

Correct Answer: Indirect agents increase endogenous transmitter availability rather than directly activating receptors

Q33. Which drug class may blunt the effect of propylhexedrine when co-administered?

• Alpha-1 agonists
• Alpha-1 antagonists or nonselective alpha blockers
• Monoamine oxidase inhibitors
• Central acetylcholinesterase inhibitors

Correct Answer: Alpha-1 antagonists or nonselective alpha blockers

Q34. Which property increases the risk of cardiovascular adverse events with propylhexedrine misuse?

• Topical use at recommended dosing
• Systemic administration or high-dose misuse
• Use with saline rinses
• Intermittent short-term use for a cold

Correct Answer: Systemic administration or high-dose misuse

Q35. Which clinical scenario should prompt referral to a physician rather than continued OTC use?

• Temporary mild nasal congestion lasting 1 day
• Persistent severe headache and chest pain after inhaler use
• Intermittent sneezing without other symptoms
• Minor nasal dryness after a single use

Correct Answer: Persistent severe headache and chest pain after inhaler use

Q36. The chemical name propylhexedrine implies presence of which functional group in its structure?

• Secondary amine with cyclohexyl portion
• Beta-lactam ring
• Sulfhydryl group
• Carboxylic acid

Correct Answer: Secondary amine with cyclohexyl portion

Q37. Which receptor subtype is primarily responsible for vasoconstriction leading to reduced nasal congestion?

• Beta-2 adrenergic receptors
• Alpha-1 adrenergic receptors
• Dopamine D1 receptors
• Muscarinic M2 receptors

Correct Answer: Alpha-1 adrenergic receptors

Q38. Which is an important pharmacology exam point about indirect sympathomimetics like propylhexedrine?

• They directly activate muscarinic receptors to cause decongestion
• Their efficacy depends on presence of endogenous norepinephrine stores in nerve terminals
• They are antagonists at adrenergic receptors
• They require enzymatic activation by MAO to work

Correct Answer: Their efficacy depends on presence of endogenous norepinephrine stores in nerve terminals

Q39. Which of the following adverse effects could result from excessive alpha-adrenergic stimulation by propylhexedrine?

• Hypotension and syncope
• Nasal mucosal ischemia and ulceration
• Excessive salivation
• Central respiratory depression

Correct Answer: Nasal mucosal ischemia and ulceration

Q40. Which pharmacological test would best distinguish an indirect from a direct sympathomimetic effect?

• Response in absence of neuronal norepinephrine stores (e.g., after reserpine)
• Measurement of serum glucose only
• Assessment of anticholinergic side effects
• Evaluation of liver enzyme elevation

Correct Answer: Response in absence of neuronal norepinephrine stores (e.g., after reserpine)

Q41. Which label warning is most relevant for propylhexedrine inhalers?

• May cause drowsiness and should not be used with alcohol
• Do not use more frequently than recommended to avoid rebound congestion
• Safe in all cardiovascular disease patients
• Can be used in combination with MAO inhibitors

Correct Answer: Do not use more frequently than recommended to avoid rebound congestion

Q42. A pharmacology student should remember that indirect sympathomimetics require which of the following to exert effect?

• External administration of norepinephrine
• Presence of endogenous catecholamine stores in presynaptic neurons
• Direct binding to postsynaptic adrenergic receptors only
• Concurrent antihistamine therapy

Correct Answer: Presence of endogenous catecholamine stores in presynaptic neurons

Q43. Which of the following is a potential neuropsychiatric adverse effect with systemic stimulant exposure?

• Psychosis, agitation, paranoia
• Marked sedation and hyporeactivity only
• Improved long-term mood stabilization
• Permanent memory enhancement

Correct Answer: Psychosis, agitation, paranoia

Q44. In the context of drug design, propylhexedrine’s cyclohexyl ring contributes to:

• Water solubility and lack of lipophilicity
• Lipophilicity and potential for CNS penetration if systemically absorbed
• Irreversible enzyme inhibition
• Chelation of metal ions

Correct Answer: Lipophilicity and potential for CNS penetration if systemically absorbed

Q45. Which pharmacological strategy reduces the risk of rhinitis medicamentosa from decongestant overuse?

• Increasing dose gradually
• Limiting duration of continuous use and using saline or intranasal steroids for longer-term relief
• Combining multiple topical decongestants simultaneously
• Switching to oral sympathomimetics indefinitely

Correct Answer: Limiting duration of continuous use and using saline or intranasal steroids for longer-term relief

Q46. Which clinical sign would most strongly indicate systemic toxicity from misused propylhexedrine?

• Isolated mild nasal dryness
• Severe hypertension with chest pain and arrhythmia
• Gradual improvement in nasal airflow
• Transient sneezing

Correct Answer: Severe hypertension with chest pain and arrhythmia

Q47. For pharmacology exams, which term describes the reduced effect of a drug after repeated use requiring higher doses for same effect?

• Potentiation
• Tolerance
• Sensitization
• Synergy

Correct Answer: Tolerance

Q48. Which of the following is a reasonable OTC recommendation for a patient with occasional nasal congestion?

• Use a topical decongestant continuously for one month
• Use a topical decongestant for up to 3–7 days and consider saline or steroid if longer symptoms persist
• Avoid all decongestants and only use antibiotics
• Use multiple topical sympathomimetics at once to increase effect

Correct Answer: Use a topical decongestant for up to 3–7 days and consider saline or steroid if longer symptoms persist

Q49. Which interaction can potentiate cardiovascular effects of propylhexedrine?

• Concurrent use of topical emollients
• Concomitant systemic sympathomimetics or stimulants (e.g., pseudoephedrine, cocaine)
• Oral probiotics
• Topical antihistamines for skin

Correct Answer: Concomitant systemic sympathomimetics or stimulants (e.g., pseudoephedrine, cocaine)

Q50. For a B.Pharm student preparing for exams, which study focus will most help understand propylhexedrine pharmacology?

• Detailed mechanism of DNA replication
• Adrenergic pharmacodynamics, indirect sympathomimetic mechanisms, safety and interactions
• Topical antifungal drug classes only
• Vaccine storage temperatures

Correct Answer: Adrenergic pharmacodynamics, indirect sympathomimetic mechanisms, safety and interactions

Download